Impact Biomedical Inc. (IBO): Total Assets
$17.41M
As of 2025-12-31
$16.75M
As of 2026-06-30
-27.9%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.41M | -14.2% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $20.29M | -54.5% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $44.63M | -4.0% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $46.50M | n/a | 2024-02-20, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
Compare IBO, LYEL, TLPH, NTHI side by side · Screen every company in Pharmaceutical Preparations ↗